Mur J, Cox SR, Marioni RE, et al. Increase in anticholinergic burden from 1990 to 2015: age-period-cohort analysis in UK biobank. Br J Clin Pharmacol. 2022;88:983–93.

Article  PubMed  Google Scholar 

Collamati A, Martone AM, Poscia A, et al. Anticholinergic drugs and negative outcomes in the older population: from biological plausibility to clinical evidence. Aging Clin Exp Res. 2016;28:25–35.

Article  PubMed  Google Scholar 

Matsumoto A, Yoshimura Y, Nagano F, et al. Exploring the impact of anticholinergic burden on urinary independence: insights from a post-stroke cohort of older adults. Int J Clin Pharm. 2024;46:910–7. https://doi.org/10.1007/s11096-024-01725-x.

Article  PubMed  CAS  Google Scholar 

de Germay S, Rueter M, Montastruc F, et al. Trends of atropinic (anticholinergic) exposure in the elderly: a 10-year analysis in the French EGB database. Fundam Clin Pharmacol. 2019;33:471–8.

Article  PubMed  Google Scholar 

Morin L, Johnell K, Laroche ML, et al. The epidemiology of polypharmacy in older adults: register-based prospective cohort study. Clin Epidemiol. 2018;10:289.

Article  PubMed  PubMed Central  Google Scholar 

Chowdhury SR, Das DC, Sunna TC, et al. Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis. eClinical Med. 2023. https://doi.org/10.1016/j.eclinm.2023.101860.

Article  Google Scholar 

Hellemans L, Nuyts S, Hias J, et al. Polypharmacy and excessive polypharmacy in community-dwelling middle aged and aged adults between 2011 and 2015. Int J Clin Pract. 2021;75:e13942.

Article  PubMed  Google Scholar 

Richardson K, Fox C, Maidment I, et al. Anticholinergic drugs and risk of dementia: case-control study. BMJ. 2018;361:k1315.

Article  PubMed  PubMed Central  Google Scholar 

Ali S, Peterson GM, Bereznicki LR, et al. Association between anticholinergic drug burden and mortality in older people: a systematic review. Eur J Clin Pharmacol. 2020;76:319–35.

Article  PubMed  Google Scholar 

Zia A, Kamaruzzaman S, Myint PK, et al. Anticholinergic burden is associated with recurrent and injurious falls in older individuals. Maturitas. 2016;84:32–7.

Article  PubMed  Google Scholar 

Boustani M, Campbell N, Munger S, et al. Impact of anticholinergics on the aging brain: a review and practical application. Aging Health. 2008;4:311–20.

Article  CAS  Google Scholar 

Rudolph JL, Salow MJ, Angelini MC, et al. The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med. 2008;168:508–13. https://doi.org/10.1001/archinternmed.2007.106.

Article  PubMed  Google Scholar 

Carnahan RM, Lund BC, Perry PJ, et al. The anticholinergic drug scale as a measure of drug-related anticholinergic burden: associations with serum anticholinergic activity. J Clin Pharmacol. 2006;46:1481–6.

Article  PubMed  CAS  Google Scholar 

Lozano-Ortega G, Johnston KM, Cheung A, et al. A review of published anticholinergic scales and measures and their applicability in database analyses. Arch Gerontol Geriatr. 2020;87:103885.

Article  PubMed  CAS  Google Scholar 

Grossi CM, Richardson K, Savva GM, et al. Increasing prevalence of anticholinergic medication use in older people in England over 20 years: cognitive function and ageing study I and II. BMC Geriatr. 2020;20:1–8.

Article  Google Scholar 

Lim LM, McStea M, Chung WW, et al. Prevalence, risk factors and health outcomes associated with polypharmacy among urban community-dwelling older adults in multi-ethnic Malaysia. PLoS ONE. 2017;12:e0173466.

Article  PubMed  PubMed Central  Google Scholar 

Shahar S, Omar A, Vanoh D, et al. Approaches in methodology for population-based longitudinal study on neuroprotective model for healthy longevity (TUA) among Malaysian older adults. Aging Clin Exp Res. 2016;28:1089–104.

Article  PubMed  Google Scholar 

Ibrahim NA, Wong YY, Lean QY, et al. Medication self-management among older adults with cognitive frailty. Res Soc Adm Pharm. 2024;20:172–81.

Article  Google Scholar 

Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the depression anxiety stress scales (DASS) with the beck depression and anxiety inventories. Behav Res Ther. 1995;33(3):335–43.

Article  PubMed  CAS  Google Scholar 

Sheikh JI, Yesavage JA. Geriatric depression scale (GDS): recent evidence and development of a shorter version. Clin Gerontol. 2014;5:165–73.

Google Scholar 

Campbell NL, Maidment I, Fox C, et al. The 2012 update to the anticholinergic cognitive burden scale. J Am Geriatr Soc. 2013;61(S1):S142–3. https://doi.org/10.1111/jgs.2013.61.issue-s1.

Article  Google Scholar 

Xu XJ, Myint PK, Kioh SH, et al. A five-year prospective evaluation of anticholinergic cognitive burden and falls in the Malaysian elders longitudinal research (MELoR) study. Arch Gerontol Geriatr. 2022;98:104535.

Article  PubMed  CAS  Google Scholar 

Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)—a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377–81.

Article  PubMed  Google Scholar 

Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.

Article  PubMed  PubMed Central  Google Scholar 

Moriarty F, Bennett K, Fahey T, et al. Longitudinal prevalence of potentially inappropriate medicines and potential prescribing omissions in a cohort of community-dwelling older people. Eur J Clin Pharmacol. 2015;71:473–82.

Article  PubMed  PubMed Central  Google Scholar 

Myint PK, Fox C, Kwok CS, et al. Total anticholinergic burden and risk of mortality and cardiovascular disease over 10 years in 21,636 middle-aged and older men and women of EPIC-Norfolk prospective population study. Age Ageing. 2015;44:219–25.

Article  PubMed  Google Scholar 

Mahase E. FDA recalls ranitidine medicines over potential cancer causing impurity. BMJ. 2019;367:l5832.

Article  PubMed  Google Scholar 

Sundus A, Sellappans R, Tan MP. Informing policy makers in developing countries: practices and limitations of geriatric home medication review in Malaysia-a qualitative inquiry. Asian Pac J Trop Med. 2024;17:21–9.

Article  Google Scholar 

Kuo S, Ou HT, Wang CJ. Managing medication supply chains: lessons learned from Taiwan during the COVID-19 pandemic and preparedness planning for the future. J Am Pharm Assoc. 2021;61(1):e12–5.

Article  CAS  Google Scholar 

Long CM, Chan SY. The paradigm shift of pharmacy profession at post-COVID-19 era in Malaysia. Malays J Pharm. 2022;8:iii–v.

Article  Google Scholar 

Kovell LC, Ahmed HM, Misra S, et al. US hypertension management guidelines: a review of the recent past and recommendations for the future. J Am Heart Assoc. 2015;4:e002315.

Article  PubMed  PubMed Central  Google Scholar 

Bramlage P, Hasford J. Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment–a review. Cardiovasc Diabetol. 2009;8:1–13.

Article  Google Scholar 

Ministry of Health Malaysia. Specialty & subspecialty framework of ministry of health hospitals under 11th Malaysia plan (2016–2020). 2016. ISBN: 978-967-0509-17-4.

Martinez-Amezcua P, Haque W, Khera R, et al. The upcoming epidemic of heart failure in South Asia. Circ Heart Fail. 2020;13:e007218.

Article  PubMed  Google Scholar 

Kay GG. The effects of antihistamines on cognition and performance. J Allergy Clin Immunol. 2000;105:S622–7.

Article  PubMed  CAS  Google Scholar 

Wong RSY, Abdul Kadir SY. Medical education in Malaysia: quality versus quantity. Perspect Med Educ. 2017;6:10–1.

Article  PubMed  PubMed Central  Google Scholar 

Munawar K, Mukhta